These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 1136810)
21. Bioequivalence of drug products. Koritz GD J Am Vet Med Assoc; 1980 Aug; 177(3):279-81. PubMed ID: 7440334 [No Abstract] [Full Text] [Related]
22. [When is determination of drug concentrations in plasma useful or necessary?]. Roots I Internist (Berl); 1986 Jan; 27(1):40-52. PubMed ID: 3514516 [No Abstract] [Full Text] [Related]
23. [Individualization of drug dosage by therapeutic monitoring in plasma and the application of pharmacokinetic principles]. Klotz U J Clin Chem Clin Biochem; 1983 Nov; 21(11):649-58. PubMed ID: 6655441 [TBL] [Abstract][Full Text] [Related]
24. [Problems of pharmacokinetics]. Gillmann H Arzneimittelforschung; 1972 Feb; 22(2):283-5. PubMed ID: 5067477 [No Abstract] [Full Text] [Related]
25. Pharmacokinetic concepts and applications affecting the clinical laboratory: I. General concepts and applications. Schumacher GE Am J Med Technol; 1981 Mar; 47(3):157-61. PubMed ID: 7223760 [TBL] [Abstract][Full Text] [Related]
26. Variation in response to drugs: Part I. Patient, physiological and disease variables. Fraser HS; Tibbits RC West Indian Med J; 1983 Mar; 32(1):7-16. PubMed ID: 6346692 [No Abstract] [Full Text] [Related]
27. Individualization of drug dosage regimens. Platt DR Clin Lab Med; 1987 Jun; 7(2):289-99. PubMed ID: 3301171 [TBL] [Abstract][Full Text] [Related]
28. The significance of properly designed pre-clinical studies in the clinical evaluation of new drugs. Garrett ER Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):6-20. PubMed ID: 4924331 [No Abstract] [Full Text] [Related]
29. [Drug monitoring in intensive care medicine]. Ochs HR; Gugler R Internist (Berl); 1984 Jun; 25(6):336-40. PubMed ID: 6384102 [No Abstract] [Full Text] [Related]
32. Definition and implications of dose-dependent kinetics in clinical medicine. Holtzman JL Drug Metab Rev; 1983; 14(6):1103-17. PubMed ID: 6426917 [No Abstract] [Full Text] [Related]
33. [Measurements of plasma drug concentration as a guide in drug therapy]. Bircher J Ther Umsch; 1980 Oct; 37(10):918-23. PubMed ID: 7455956 [No Abstract] [Full Text] [Related]
34. Fitting a general sigmoid model to pharmacological response curves [proceedings]. Davey A; Marriott A; Stockham MA Br J Pharmacol; 1976 Oct; 58(2):289P-290P. PubMed ID: 974407 [No Abstract] [Full Text] [Related]
35. Using pharmacokinetics in drug therapy. VI: Comparing methods for dealing with nonlinear drugs like phenytoin. Schumacher GE Am J Hosp Pharm; 1980 Jan; 37(1):128-32. PubMed ID: 7361770 [TBL] [Abstract][Full Text] [Related]
36. Saliva-plasma drug concentration ratios during absorption: theoretical considerations and pharmacokinetic implications. Posti J Pharm Acta Helv; 1982; 57(3):83-92. PubMed ID: 7071071 [No Abstract] [Full Text] [Related]
37. Initial human trials with an investigational new drug (phase I and 2): planning an management. Vaidya AB; Vaidya RA J Postgrad Med; 1981 Oct; 27(4):197-213. PubMed ID: 7338825 [No Abstract] [Full Text] [Related]
38. Primer on clinical pharmacokinetics. Bauer LA Am J Hosp Pharm; 1983 Oct; 40(10):1637-41. PubMed ID: 6638025 [TBL] [Abstract][Full Text] [Related]
39. [An electronic simulator for demonstration of pharmacokinetic concentration patterns]. Bättig P Arzneimittelforschung; 1972 Mar; 22(3):603-6. PubMed ID: 5067940 [No Abstract] [Full Text] [Related]